|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 165 | - | - | 102 | 61.8 | 32 | 19.4 | 18 | 10.9 | 13 | 7.9 |
| 2015-2019 | 172 | - | - | 104 | 60.5 | 32 | 18.6 | 20 | 11.6 | 16 | 9.3 |
| 2014-2018 | 150 | - | - | 91 | 60.7 | 27 | 18.0 | 17 | 11.3 | 15 | 10.0 |
| 2013-2017 | 140 | - | - | 84 | 60.0 | 30 | 21.4 | 11 | 7.9 | 15 | 10.7 |
| 2012-2016 | 139 | - | - | 85 | 61.2 | 32 | 23.0 | 10 | 7.2 | 12 | 8.6 |
| 2011-2015 | 143 | - | - | 98 | 68.5 | 25 | 17.5 | 9 | 6.3 | 11 | 7.7 |
| 2010-2014 | 144 | - | - | 101 | 70.1 | 25 | 17.4 | 7 | 4.9 | 11 | 7.6 |
| 2009-2013 | 166 | - | - | 122 | 73.5 | 26 | 15.7 | 5 | 3.0 | 13 | 7.8 |
| 2008-2012 | 180 | - | - | 134 | 74.4 | 24 | 13.3 | 5 | 2.8 | 17 | 9.4 |
| 2007-2011 | 186 | - | - | 138 | 74.2 | 23 | 12.4 | 4 | 2.2 | 21 | 11.3 |
| 2006-2010 | 192 | - | - | 141 | 73.4 | 24 | 12.5 | 3 | 1.6 | 24 | 12.5 |
| 2005-2009 | 201 | - | - | 147 | 73.1 | 22 | 10.9 | 6 | 3.0 | 26 | 12.9 |
| 2004-2008 | 195 | - | - | 139 | 71.3 | 22 | 11.3 | 6 | 3.1 | 28 | 14.4 |
| 2003-2007 | 199 | - | - | 139 | 69.8 | 23 | 11.6 | 6 | 3.0 | 31 | 15.6 |
| 2002-2006 | 200 | - | - | 138 | 69.0 | 24 | 12.0 | 8 | 4.0 | 30 | 15.0 |
| 2001-2005 | 211 | 2 | 0.9 | 137 | 64.9 | 30 | 14.2 | 10 | 4.7 | 32 | 15.2 |
| 2000-2004 | 204 | 2 | 1.0 | 126 | 61.8 | 32 | 15.7 | 9 | 4.4 | 35 | 17.2 |
| 1999-2003 | 205 | 3 | 1.5 | 119 | 58.0 | 35 | 17.1 | 13 | 6.3 | 35 | 17.1 |
| 1998-2002 | 196 | 3 | 1.5 | 113 | 57.7 | 31 | 15.8 | 17 | 8.7 | 32 | 16.3 |
| 1997-2001 | 184 | 3 | 1.6 | 106 | 57.6 | 29 | 15.8 | 15 | 8.2 | 31 | 16.8 |
| 1996-2000 | 159 | 1 | 0.6 | 96 | 60.4 | 22 | 13.8 | 13 | 8.2 | 27 | 17.0 |
| 1995-1999 | 157 | 1 | 0.6 | 100 | 63.7 | 22 | 14.0 | 12 | 7.6 | 22 | 14.0 |
| 1994-1998 | 174 | 1 | 0.6 | 119 | 68.4 | 23 | 13.2 | 8 | 4.6 | 23 | 13.2 |
| 1993-1997 | 194 | 1 | 0.5 | 134 | 69.1 | 28 | 14.4 | 5 | 2.6 | 26 | 13.4 |
| 1992-1996 | 228 | 1 | 0.4 | 157 | 68.9 | 34 | 14.9 | 8 | 3.5 | 28 | 12.3 |
| 1991-1995 | 256 | 1 | 0.4 | 175 | 68.4 | 35 | 13.7 | 12 | 4.7 | 33 | 12.9 |
| 1990-1994 | 259 | 1 | 0.4 | 168 | 64.9 | 38 | 14.7 | 12 | 4.6 | 40 | 15.4 |
| 1989-1993 | 228 | - | - | 143 | 62.7 | 31 | 13.6 | 14 | 6.1 | 40 | 17.5 |
| 1988-1992 | 199 | - | - | 115 | 57.8 | 26 | 13.1 | 14 | 7.0 | 44 | 22.1 |
| 1987-1991 | 160 | - | - | 80 | 50.0 | 19 | 11.9 | 13 | 8.1 | 48 | 30.0 |
| 1986-1990 | 122 | - | - | 49 | 40.2 | 20 | 16.4 | 10 | 8.2 | 43 | 35.2 |
| 1985-1989 | 107 | - | - | 50 | 46.7 | 14 | 13.1 | 8 | 7.5 | 35 | 32.7 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |